Your search returned 2793 results.

Results
	1701.	Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML). [electronic resource] by Ravandi, F Jilani, I Estey, E Kantarjian, H Dey, A Aguilar, C Jitkaroon, C Giles, F O'Brien, S Keating, M Albitar, M Producer: 20070806 In: Leukemia research vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1702.	Sensitivity toward sorafenib and sunitinib varies between different activating and drug-resistant FLT3-ITD mutations. [electronic resource] by Kancha, Rama Krishna Grundler, Rebekka Peschel, Christian Duyster, Justus Producer: 20071107 In: Experimental hematology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1703.	Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: a case report. [electronic resource] by Winkler, J Rech, D Kallert, S Rech, J Meidenbauer, N Roesler, W Mackensen, A Producer: 20100930 In: Leukemia research vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1704.	Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course. [electronic resource] by Taira, Chiaki Matsuda, Kazuyuki Kamijyo, Yuka Sakashita, Kazuo Ishida, Fumihiro Kumagai, Toshiko Yamauchi, Kazuyoshi Okumura, Nobuo Honda, Takayuki Producer: 20110310 In: Clinica chimica acta; international journal of clinical chemistry vol. 412 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1705.	Flt3 signaling-dependent dendritic cells protect against atherosclerosis. [electronic resource] by Choi, Jae-Hoon Cheong, Cheolho Dandamudi, Durga B Park, Chae Gyu Rodriguez, Anthony Mehandru, Saurabh Velinzon, Klara Jung, In-Hyuk Yoo, Ji-Young Oh, Goo Taeg Steinman, Ralph M Producer: 20120118 In: Immunity vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1706.	Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. [electronic resource] by Pratcorona, Marta Brunet, Salut Nomdedéu, Josep Ribera, Josep Maria Tormo, Mar Duarte, Rafael Escoda, Lourdes Guàrdia, Ramon Queipo de Llano, M Paz Salamero, Olga Bargay, Joan Pedro, Carmen Martí, Josep Maria Torrebadell, Montserrat Díaz-Beyá, Marina Camós, Mireia Colomer, Dolors Hoyos, Montserrat Sierra, Jorge Esteve, Jordi Producer: 20130528 In: Blood vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1707.	Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approach. [electronic resource] by Chang Hsu, Yung Ke, Yi-Yu Shiao, Hui-Yi Lee, Chieh-Chien Lin, Wen-Hsing Chen, Chun-Hwa Yen, Kuei-Jung Hsu, John T-A Chang, Chungming Hsieh, Hsing-Pang Producer: 20150221 In: ChemMedChem vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1708.	The NPM1 mutation type has no impact on survival in cytogenetically normal AML. [electronic resource] by Pastore, Friederike Greif, Philipp A Schneider, Stephanie Ksienzyk, Bianka Mellert, Gudrun Zellmeier, Evelyn Braess, Jan Sauerland, Cristina M Heinecke, Achim Krug, Utz Berdel, Wolfgang E Buechner, Thomas Woermann, Bernhard Hiddemann, Wolfgang Spiekermann, Karsten Producer: 20151221 In: PloS one vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1709.	Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells. [electronic resource] by Skwarska, Anna Augustin, Ewa Beffinger, Michał Wojtczyk, Anita Konicz, Sonia Laskowska, Katarzyna Polewska, Joanna Producer: 20150812 In: Biochemical pharmacology vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1710.	Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia. [electronic resource] by Williams, Casey B Kambhampati, Suman Fiskus, Warren Wick, Jo Dutreix, Catherine Ganguly, Siddartha Aljitawi, Omar Reyes, Ruben Fleming, Allan Abhyankar, Sunil Bhalla, Kapil N McGuirk, Joseph P Producer: 20140801 In: Pharmacotherapy vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1711.	Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. [electronic resource] by Reikvam, H Øyan, A M Kalland, K H Hovland, R Hatfield, K J Bruserud, Ø Producer: 20131118 In: Cell proliferation vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1712.	Molecularly targeted therapies for acute myeloid leukemia. [electronic resource] by Stein, Eytan M Producer: 20161014 In: Hematology. American Society of Hematology. Education Program vol. 2015 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1713.	Generation and Assessment of Fusions Between HDACi and TKi. [electronic resource] by Mahboobi, Siavosh Pilsl, Bernadette Sellmer, Andreas Producer: 20180109 In: Methods in molecular biology (Clifton, N.J.) vol. 1510 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1714.	Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation. [electronic resource] by Gaballa, Sameh Saliba, Rima Oran, Betul Brammer, Jonathan E Chen, Julianne Rondon, Gabriela Alousi, Amin M Kebriaei, Partow Marin, David Popat, Uday R Andersson, Borje S Shpall, Elizabeth J Jabbour, Elias Daver, Naval Andreeff, Michael Ravandi, Farhad Cortes, Jorge Patel, Keyur Champlin, Richard E Ciurea, Stefan O Producer: 20170717 In: American journal of hematology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1715.	Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors. [electronic resource] by Koda, Yasuko Kikuzato, Ko Mikuni, Junko Tanaka, Akiko Yuki, Hitomi Honma, Teruki Tomabechi, Yuri Kukimoto-Niino, Mutsuko Shirouzu, Mikako Shirai, Fumiyuki Koyama, Hiroo Producer: 20171121 In: Bioorganic & medicinal chemistry letters vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1716.	The importance of FLT3 mutational analysis in acute myeloid leukemia. [electronic resource] by Patnaik, Mrinal M Producer: 20190606 In: Leukemia & lymphoma vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1717.	FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of Heterozygosity. [electronic resource] by Gaymes, Terry J Mohamedali, Azim Eiliazadeh, Anthony L Darling, David Mufti, Ghulam J Producer: 20170807 In: Cancer research vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1718.	Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine. [electronic resource] by Li, Xia Yan, Xiao Guo, Wenjian Huang, Xin Huang, Jiansong Yu, Mengxia Ma, Zhixin Xu, Yu Huang, ShuJuan Li, Chenying Zhou, Yile Jin, Jie Producer: 20180216 In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1719.	Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study. [electronic resource] by Harada, Yasuhiko Nagata, Yasunobu Kihara, Rika Ishikawa, Yuichi Asou, Norio Ohtake, Shigeki Miyawaki, Shuichi Sakura, Toru Ozawa, Yukiyasu Usui, Noriko Kanamori, Heiwa Ito, Yoshikazu Imai, Kiyotoshi Suehiro, Youko Kobayashi, Shinichi Kitamura, Kunio Sakaida, Emiko Onizuka, Makoto Takeshita, Akihiro Ishida, Fumihiro Suzushima, Hitoshi Ishizawa, Kenichi Naoe, Tomoki Matsumura, Itaru Miyazaki, Yasushi Ogawa, Seishi Kiyoi, Hitoshi Producer: 20190123 In: Leukemia research vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1720.	The FLT3-ITD mutation and the expression of its downstream signaling intermediates STAT5 and Pim-1 are positively correlated with CXCR4 expression in patients with acute myeloid leukemia. [electronic resource] by Cao, Tingyong Jiang, Nenggang Liao, Hongyan Shuai, Xiao Su, Jun Zheng, Qin Producer: 20201020 In: Scientific reports vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2793 results.